À LA UNE de l'actualité médicale
Modern radiation therapy employs intensity modulation, which uses the inverse optimization technique to produce the corresponding dose distribution from the optimum target conditions based on the clinical target and organs at risk (OARs) dose . Individual experiences and the amount of effort spent developing a plan impact a plan’s quality to a great extent [1], as different dose lead to different...
Bi Suyan et al.
European journal of medical research 2023; 28(1): 309
Lire la suite
Bi Suyan et al.
European journal of medical research 2023; 28(1): 309
Lire la suite
Prostate cancer (PCa) is the leading cause of cancer-related deaths in men worldwide. Approximately 20% of PCa patients die each year, seriously endangering men’s health and increasing the burden on society [1, 2]. Currently, androgen deprivation therapy (ADT) is widely accepted as the clinical paradigm for the treatment of advanced PCa and metastatic disease [3]. However, the vast majority of...
Xu Wenjing et al.
Cancer Cell International 2023; 23(1): 190
Lire la suite
Xu Wenjing et al.
Cancer Cell International 2023; 23(1): 190
Lire la suite
Prostate cancer (PrCa) is the second most common cancer and the fifth leading cause of death among men worldwide, with around 375,000 men dying each year [1]. PrCa has been well known to have a higher prevalence among middle-aged and older men. Moreover, incidence rates of PrCa have been found to increase steeply from age 50, with two-thirds of cases being diagnosed over the age of 70 [2].
PrCa most...
Iijima Kazutaka et al.
Journal of Medical Case Reports 2023; 17(1): 376
Lire la suite
Iijima Kazutaka et al.
Journal of Medical Case Reports 2023; 17(1): 376
Lire la suite
Prostate cancer (PCa) is one of the most common malignant cancer in man. It is estimated that approximately 1.3 million new cases worldwide every year, and currently about 10 million people are living with PCa [1, 2]. MRI plays an important role in localizing, diagnosis, and staging of PCa [3–5]; moreover, previous studies demonstrated that MRGB is superior to conventional standard...
Hu Beibei et al.
Cancer imaging 2023; 23(1): 82
Lire la suite
Hu Beibei et al.
Cancer imaging 2023; 23(1): 82
Lire la suite
